EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunopathology in human tuberculosis

Thomas J Scriba iD, Mahlatse Maseeme, Carly Young, Laura Taylor iD, Alasdair J Leslie iD

Science Immunology · 13.12.2024 · 9 (102)

DOI: 10.1126/sciimmunol.ado5951 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Immunology, erschienen am 13.12.2024. Verfasst von Thomas J Scriba und 4 weiteren Autor:innen. Beteiligte Einrichtung: South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medi…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 173 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis ( M.tb ) is a bacterial pathogen that has evolved in humans, and its interactions with the host are complex and best studied in humans. Myriad immune pathways are involved in infection control, granuloma formation, and progression to tuberculosis (TB) disease. Inflammatory cells, such as macrophages, neutrophils, conventional and unconventional T cells, B cells, NK cells, and innate lymphoid cells, interact via cytokines, cell-cell communication, and eicosanoid signaling to contain or eliminate infection but can alternatively mediate pathological changes required for pathogen transmission. Clinical manifestations include pulmonary and extrapulmonary TB, as well as post-TB lung disease. Risk factors for TB progression, in turn, largely relate to immune status and, apart from traditional chemotherapy, interventions primarily target immune mechanisms, highlighting the critical role of immunopathology in TB. Maintaining a balance between effector mechanisms to achieve protective immunity and avoid detrimental inflammation is central to the immunopathogenesis of TB. Many research gaps remain and deserve prioritization to improve our understanding of human TB immunopathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisHumansAnimals

Autor:innen und Institutionen

  • South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Africa Health Research Institute, Durban, South Africa.
  • College of Heath Sciences, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Forensic Pathology Services, Western Cape Government/University of Cape Town, Cape Town, South Africa.
  • University College London, London, UK.

ORCID-Profile: Thomas J Scriba, Laura Taylor, Alasdair J Leslie

Zitieren

APA

Scriba, T. J., Maseeme, M., Young, C., Taylor, L., & Leslie, A. J. (2024). Immunopathology in human tuberculosis. Science Immunology, 9(102). https://doi.org/10.1126/sciimmunol.ado5951

Vancouver

Scriba TJ, Maseeme M, Young C, Taylor L, Leslie AJ. Immunopathology in human tuberculosis. Science Immunology. 2024;9(102). doi:10.1126/sciimmunol.ado5951

BibTeX
@article{Scriba2024,
  author = {Scriba, Thomas J and Maseeme, Mahlatse and Young, Carly and Taylor, Laura and Leslie, Alasdair J},
  title = {Immunopathology in human tuberculosis},
  journal = {Science Immunology},
  year = {2024},
  volume = {9},
  number = {102},
  doi = {10.1126/sciimmunol.ado5951}
}
Kostenlos starten →